SANGANI HOSPITALS LIMITED vs TORRENT PHARMACEUTICALS L

A side-by-side comparison of SANGANI HOSPITALS LIMITED (SANGANI) and TORRENT PHARMACEUTICALS L (TORNTPHARM) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, TORRENT PHARMACEUTICALS L leads SANGANI vs TORNTPHARM on 8 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability13
  • Growth20
  • Size & financial health13
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

24.19
P/E ratio
77.92
1.73
P/B ratio
18.67
0.00%
Dividend yield
0.76%
₹2.17
EPS
₹63.92

Profitability

TORNTPHARM takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

7.76%
Return on equity
27.40%
17.00%
Return on capital
15.00%
8.00%
EBITDA margin
33.00%
3.74%
Net margin
15.29%

Growth

SANGANI takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

88.40%
Revenue CAGR (3Y)
13.27%
25.99%
Profit CAGR (3Y)
19.75%

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹62 Cr
Market cap
₹1.90L Cr
₹107 Cr
Revenue
₹13,980 Cr
₹4 Cr
Net profit
₹2,138 Cr
0.05
Debt / equity
1.69
SANGANI HOSPITALS LIMITED
  • + ["Company is almost debt free.", "Company's working capital requirements have reduced from 37.9 days to 29.3 days"]
  • ["Though the company is reporting repeated profits, it is not paying out dividend", "Company has a low return on equity of 8.36% over last 3 years.", "Company has high debtors of 210 days."]
TORRENT PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
SANGANI HOSPITALS LIMITED full analysis TORRENT PHARMACEUTICALS L full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

SANGANI vs TORNTPHARM: Share Price, Valuation & Which to Buy | DocStoX